HomeCompareTHLLY vs JNJ

THLLY vs JNJ: Dividend Comparison 2026

THLLY yields 1.48% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 THLLY wins by $18.66M in total portfolio value
10 years
THLLY
THLLY
● Live price
1.48%
Share price
$58.80
Annual div
$0.87
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.69M
Annual income
$16,539,735.12
Full THLLY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — THLLY vs JNJ

📍 THLLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTHLLYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, THLLY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
THLLY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THLLY
Annual income on $10K today (after 15% tax)
$125.77/yr
After 10yr DRIP, annual income (after tax)
$14,058,774.85/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, THLLY beats the other by $14,054,788.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THLLY + JNJ for your $10,000?

THLLY: 50%JNJ: 50%
100% JNJ50/50100% THLLY
Portfolio after 10yr
$9.36M
Annual income
$8,272,212.26/yr
Blended yield
88.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

THLLY
Analyst Ratings
3
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
2.5
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THLLY buys
0
JNJ buys
0
No recent congressional trades found for THLLY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTHLLYJNJ
Forward yield1.48%2.13%
Annual dividend / share$0.87$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$18.69M$30.3K
Annual income after 10y$16,539,735.12$4,689.40
Total dividends collected$18.49M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: THLLY vs JNJ ($10,000, DRIP)

YearTHLLY PortfolioTHLLY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,996$295.92$10,592$272.30+$404.00THLLY
2$12,374$608.20$11,289$357.73+$1.1KTHLLY
3$14,519$1,279.29$12,123$472.89+$2.4KTHLLY
4$18,341$2,805.80$13,141$629.86+$5.2KTHLLY
5$26,250$6,625.07$14,408$846.81+$11.8KTHLLY
6$45,811$17,723.08$16,021$1,151.60+$29.8KTHLLY
7$106,830$57,812.15$18,122$1,588.22+$88.7KTHLLY
8$366,301$251,992.97$20,930$2,228.20+$345.4KTHLLY
9$2,006,969$1,615,026.94$24,792$3,191.91+$1.98MTHLLY
10$18,687,192$16,539,735.12$30,274$4,689.40+$18.66MTHLLY

THLLY vs JNJ: Complete Analysis 2026

THLLYStock

Thales S.A. provides various solutions for civilian and military customers in the aeronautics, space, defense, security, ground transportation, and digital security markets worldwide. It operates through Aerospace, Transport, Defence & Security, and Digital Identity & Security segments. The company offers communications, command, and control systems; mission services and support; protection and mission/combat systems; surveillance, detection, and intelligence systems; training and simulation solutions for air, land, naval, and joint forces; and digital identity and security solutions. It also provides air traffic management solutions; flight decks and avionics equipment and functions; in-flight entertainment and connectivity systems and services; electrical systems; aerospace training solutions; navigation solutions; support and services for avionics equipment; and vision systems. In addition, the company designs, operates, and delivers satellite-based systems for telecommunications, navigation, earth observation, environmental management, exploration, and science and orbital infrastructures; signaling, communications and supervision, and fare collection management systems and related services; cybersecurity and railway digitalization systems; and main line rail, and urban and intermodal mobility solutions. Further, it provides solutions for various markets and applications, including radiology, radio frequency, microwave sources, training and simulation solutions, lasers, and microelectronics solutions for science, industry, space, defense, automotive, railways, and energy conversion platforms. Thales S.A. has a strategic agreement with Google LLC. The company was formerly known as Thomson-CSF and changed its name to Thales S.A. in 2000. Thales S.A. was founded in 1893 and is headquartered in Courbevoie, France.

Full THLLY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this THLLY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THLLY vs SCHDTHLLY vs JEPITHLLY vs OTHLLY vs KOTHLLY vs MAINTHLLY vs ABBVTHLLY vs MRKTHLLY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.